 |
National HIV/AIDS Program |  | | |
| Viramune
(nevirapine)
- Type of Drug: Nonnucleoside Reverse Transcriptase Inhibitor
-
Nonnucleoside reverse transcriptase inhibitors prevent HIV from using an enzyme called reverse transcriptase to make copies of itself. These drugs are also known as NNRTIs, nonnucleosides or "nonnukes."
Note: To reduce side effects when starting this medication, patients should take one 200 mg pill daily for the first 14 days, and then follow the schedule below. Notes on taking this medication- No food restrictions, can take with or without food
- Viramune interacts with many other drugs; persons using Viramune with those drugs may need an adjustment to their dose of the other drugs or avoid certain combinations; consult your medical provider
Side effects- Rash: rarely, rash may be severe and may require hospitalization; rash usually appears within first 3 weeks of starting drug
- Liver inflammation; rarely severe liver damage; liver test results should be monitored closely for the first 18 weeks that you take Viramune
- Nausea; abdominal discomfort
See accompanying chart: Tips for Common Side Effects My doctor's instructionsDisclaimer:This information is not meant to substitute for advice from your medical provider or pharmacist. If you have any questions about your medication dosing, talk to your medical provider or pharmacist. | | | |
|
| | |
|
| Reviewed/Updated Date: September 28, 2008 |
|
